Literature DB >> 6735463

Partially purified antigen preparations of Toxoplasma gondii protect against lethal infection in mice.

F G Araujo, J S Remington.   

Abstract

Antigens of Toxoplasma gondii eluted from polyacrylamide gels after electrophoresis under reducing conditions were examined for their capacity to react with antibodies from infected humans, to induce antibody formation, and to protect mice against T. gondii. Antigens with approximate molecular weights of 35,000 and 14,000 strongly reacted in an enzyme-linked immunosorbent assay of human immunoglobulin M (IgM) and IgG antibodies to T. gondii. Mice injected with the eluted antigen preparations formed antibodies that reacted differently in four serological tests for Toxoplasma antibodies. All mice formed antibodies that reacted in the IgG and IgM enzyme-linked immunosorbent assay. Antibodies reacting in the conventional indirect immunofluorescent antibody test were detected in all mice except those injected with low-molecular-weight (14,000 or less) antigens. Sabin-Feldman dye test antibodies were not detected in any of the mice. Antibodies reacting in the latex agglutination test were detected mainly in mice injected with antigens with an approximate molecular weight of 66,000. Challenge of the injected mice with a lethal inoculum of T. gondii revealed that the highest survival rate was in animals that received antigens with approximate molecular weights of 35,000 and 14,000.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6735463      PMCID: PMC263287          DOI: 10.1128/iai.45.1.122-126.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Induction of resistance to Toxoplasma gondii in human macrophages by soluble lymphocyte products.

Authors:  S E Anderson; S Bautista; J S Remington
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

2.  A microplate enzyme-immunoassay for toxoplasma antibody.

Authors:  A Voller; D E Bidwell; A Bartlett; D G Fleck; M Perkins; B Oladehin
Journal:  J Clin Pathol       Date:  1976-02       Impact factor: 3.411

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Comparison of the indirect fluorescent antibody test and methylene blue dye test for detection of antibodies to Toxoplasma gondii.

Authors:  B C Walton; B M Benchoff; W H Brooks
Journal:  Am J Trop Med Hyg       Date:  1966-03       Impact factor: 2.345

5.  Adoptive immunity to intracellular infection.

Authors:  J K Frenkel
Journal:  J Immunol       Date:  1967-06       Impact factor: 5.422

6.  The use of killed vaccines in immunization against an intracellular parasite: Toxoplasma gondii.

Authors:  J L Krahenbuhl; J Ruskin; J S Remington
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

7.  Protection against Toxoplasma gondii in mice immunized with Toxoplasma cell fractions, RNA and synthetic polyribonucleotides.

Authors:  F G Araujo; J S Remington
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

8.  Detection and characterization of membrane antigens of Toxoplasma gondii.

Authors:  E Handman; J W Goding; J S Remington
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

9.  Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies.

Authors:  S D Sharma; J Mullenax; F G Araujo; H A Erlich; J S Remington
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

10.  Antibody responses to toxoplasma antigens in mice infected with strains of different virulence.

Authors:  E Handman; J S Remington
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

View more
  9 in total

1.  Toxoplasmacidal activity of macrophages activated by recombinant major surface antigen (P30) of Toxoplasma gondii.

Authors:  A Makioka; A Kobayashi
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

Review 2.  ABC of vascular diseases. The young patient with claudication.

Authors:  D T Reilly; J H Wolfe
Journal:  BMJ       Date:  1991-10-05

3.  Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection.

Authors:  N Debard; D Buzoni-Gatel; D Bout
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  The infection-stage-related IgG response to Toxoplasma gondii studied by immunoblotting.

Authors:  C Verhofstede; P Van Gelder; M Rabaey
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

5.  Ultrastructural localization of an intracellular Toxoplasma protein that induces protection in mice.

Authors:  L D Sibley; S D Sharma
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

6.  Serodiagnosis of toxoplasma infection using a purified parasite protein (P30).

Authors:  F Santoro; D Afchain; R Pierce; J Y Cesbron; G Ovlaque; A Capron
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

7.  Comparison of IgG antibody profiles by immunoblotting in patients with acute and previous Toxoplasma gondii infection.

Authors:  I L Moir; M M Davidson; D O Ho-Yen
Journal:  J Clin Pathol       Date:  1991-07       Impact factor: 3.411

8.  Rat model of congenital toxoplasmosis.

Authors:  J P Dubey; S K Shen
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

9.  A comparative study between excretory/secretory and autoclaved vaccines against RH strain of Toxoplasma gondii in murine models.

Authors:  Hayam Mohamed Ezz Eldin; Hanan Hussein Kamel; Abeer Fathy Badawy; Lobna Sadek Shash
Journal:  J Parasit Dis       Date:  2013-11-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.